Internal Medicine Alert (Vol. 39, No. 4) - February 28, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: February 2017

Valid through: February 2020

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Investigating the Relationship Between Achieved Blood Pressure and Cardiovascular Outcomes
  • How Is Iron Deficiency Connected to Hearing Loss?
  • Does Long-term, Low-intensity Smoking Result in Similar Mortality Risks as Heavier Smokers?
  • Pharmacology Update: Plecanatide Tablets (Trulance)
  • Clinical Briefs: Identifying Risk for Macrovascular Events in Diabetes Patients; Atrial Fibrillation Still a Mortal Disorder; Prophylaxis of Genital Herpes Recurrences with Antivirals

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases;
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • Identify cost-effective treatment regimens;
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits
  • 2.0 ABIM MOC Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

This Enduring Material activity, Internal Medicine Alert, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins Jan. 1, 2017. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 1 AAFP Prescribed credits.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

PHYSICIAN EDITOR

Stephen A. Brunton, MD
Adjunct Professor of Pharmacy Practice
College of Pharmacy
Roseman University of Health Sciences
Salt Lake City  

ASSOCIATE EDITORS

James Chan, PharmD, PhD
Associate Clinical Professor
School of Pharmacy
University of California, San Francisco

Tim Drake, PharmD, MBA, BCPS
Assistant Professor of Pharmacy
College of Pharmacy
Roseman University of Health Sciences.

William T. Elliott, MD, FACP
Assistant Clinical Professor of Medicine
University of California, San Francisco

Seema Gupta, MD, MSPH
Clinical Assistant Professor
Department of Family and Community Health
Joan C. Edwards School of Medicine
Marshall University
Huntington, WV

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
David Geffen School of Medicine
UCLA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Martin S. Lipsky, MD
Chancellor, South Jordan Campus
Roseman University of Health Sciences
South Jordan, UT

PEER REVIEWER

Gerald Roberts, MD
Senior Attending Physician
Long Island Jewish Medical Center
NS/LIJ Health Care System
New Hyde Park, NY

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott Diabetes, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Janssen, Lilly, Merck, Novo Nordisk, Sanofi, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky, MD, is a retained consultant for and serves on the speakers bureau of Allergan, Daiichi Sankyo, Lilly, and Lundbeck. Peer Reviewer Gerald Roberts, MD; Executive Editor Leslie Coplin; and Editor Jonathan Springston report no financial relationships relevant to this field of study.

Drs. Elliott, Chan, Drake, Gupta, Karpman, and Lipsky report no financial relationships relevant to this field of study.

Copyright 2017, AHC Media. All rights reserved.